- Home
- AAPG vs BLKB Comparison
AAPG vs BLKB Comparison
Compare AAPG & BLKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAPG
- BLKB
- Stock Information
- Founded
- AAPG 2009
- BLKB 1981
- Country
- AAPG China
- BLKB United States
- Employees
- AAPG N/A
- BLKB N/A
- Industry
- AAPG Biotechnology: Pharmaceutical Preparations
- BLKB Computer Software: Prepackaged Software
- Sector
- AAPG Health Care
- BLKB Technology
- Exchange
- AAPG Nasdaq
- BLKB Nasdaq
- Market Cap
- AAPG 3.6B
- BLKB 3.2B
- IPO Year
- AAPG 2025
- BLKB 2004
- Fundamental
- Price
- AAPG $37.20
- BLKB $65.28
- Analyst Decision
- AAPG Buy
- BLKB Hold
- Analyst Count
- AAPG 1
- BLKB 3
- Target Price
- AAPG N/A
- BLKB $78.67
- AVG Volume (30 Days)
- AAPG 8.5K
- BLKB 265.0K
- Earning Date
- AAPG 08-11-2025
- BLKB 07-30-2025
- Dividend Yield
- AAPG N/A
- BLKB N/A
- EPS Growth
- AAPG N/A
- BLKB N/A
- EPS
- AAPG N/A
- BLKB N/A
- Revenue
- AAPG $134,352,180.00
- BLKB $1,141,002,000.00
- Revenue This Year
- AAPG N/A
- BLKB N/A
- Revenue Next Year
- AAPG $404.41
- BLKB $4.03
- P/E Ratio
- AAPG N/A
- BLKB N/A
- Revenue Growth
- AAPG 341.77
- BLKB 0.16
- 52 Week Low
- AAPG $16.50
- BLKB $58.05
- 52 Week High
- AAPG $43.58
- BLKB $88.95
- Technical
- Relative Strength Index (RSI)
- AAPG N/A
- BLKB 50.70
- Support Level
- AAPG N/A
- BLKB $63.72
- Resistance Level
- AAPG N/A
- BLKB $74.88
- Average True Range (ATR)
- AAPG 0.00
- BLKB 1.75
- MACD
- AAPG 0.00
- BLKB 0.20
- Stochastic Oscillator
- AAPG 0.00
- BLKB 24.23
About AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.
About BLKB Blackbaud Inc.
Founded in 1981, Blackbaud provides software solutions designed to serve the "social good" community, including nonprofits, foundations, corporations, educational institutions, healthcare institutions, and individual change agents. Through M&A and organic product development efforts, the company has also moved into related areas outside core fundraising, notably into K-12 schools. The firm enables more than $100 billion in donations annually across a customer base in excess of 40,000 customers in over 100 countries.